TY - JOUR
T1 - Allometric exponents for scaling running economy in human samples
T2 - A systematic review and meta-analysis
AU - Lee, Jay
AU - Wang, Zhiwen
AU - Chen, Mingjian
AU - Liu, Siqi
AU - Yu, Qian
AU - Hu, Mingzhu
AU - Kong, Zhaowei
AU - Nie, Jinlei
N1 - Publisher Copyright:
© 2024 The Authors
PY - 2024/5/30
Y1 - 2024/5/30
N2 - Ratio-scaled VO2 is the widely used method for quantifying running economy (RE). However, this method should be criticized due to its theoretical defect and curvilinear relationship indicated by the allometric scaling, although no consensus has been achieved on the generally accepted exponent b value of body weight. Therefore, this study aimed to provide a quantitative synthesis of the reported exponents used to scale VO2 to body weight. Six electronic databases were searched based on related terms. Inclusion criteria involved human cardiopulmonary testing data, derived exponents, and reported precision statistics. The random-effects model was applied to statistically analyze exponent b. Subgroup and meta-regression analyses were conducted to explore the potential factors contributing to variation in b values. The probability of the true exponent being below 1 in future studies was calculated. The estimated b values were all below 1 and aligned with the 3/4 power law, except for the 95 % prediction interval of the estimated fat-free body weight exponent b. A publication bias and a slightly greater I2 and τ statistic were also observed in the fat-free body weight study cohort. The estimated probabilities of the true body weight exponent, full body weight exponent, and fat-free body weight exponent being lower than 1 were 93.8 % (likely), 95.1 % (very likely), and 94.5 % (likely) respectively. ‘Sex difference’, ‘age category’, ‘sporting background’, and ‘testing modality’ were four potential but critical variables that impacted exponent b. Overall, allometric-scaled RE should be measured by full body weight with exponent b raised to 3/4.
AB - Ratio-scaled VO2 is the widely used method for quantifying running economy (RE). However, this method should be criticized due to its theoretical defect and curvilinear relationship indicated by the allometric scaling, although no consensus has been achieved on the generally accepted exponent b value of body weight. Therefore, this study aimed to provide a quantitative synthesis of the reported exponents used to scale VO2 to body weight. Six electronic databases were searched based on related terms. Inclusion criteria involved human cardiopulmonary testing data, derived exponents, and reported precision statistics. The random-effects model was applied to statistically analyze exponent b. Subgroup and meta-regression analyses were conducted to explore the potential factors contributing to variation in b values. The probability of the true exponent being below 1 in future studies was calculated. The estimated b values were all below 1 and aligned with the 3/4 power law, except for the 95 % prediction interval of the estimated fat-free body weight exponent b. A publication bias and a slightly greater I2 and τ statistic were also observed in the fat-free body weight study cohort. The estimated probabilities of the true body weight exponent, full body weight exponent, and fat-free body weight exponent being lower than 1 were 93.8 % (likely), 95.1 % (very likely), and 94.5 % (likely) respectively. ‘Sex difference’, ‘age category’, ‘sporting background’, and ‘testing modality’ were four potential but critical variables that impacted exponent b. Overall, allometric-scaled RE should be measured by full body weight with exponent b raised to 3/4.
KW - Allometric scaling
KW - Fat-free body weight
KW - Full body weight
KW - Meta-analysis
KW - Running economy
UR - http://www.scopus.com/inward/record.url?scp=85193440920&partnerID=8YFLogxK
U2 - 10.1016/j.heliyon.2024.e31211
DO - 10.1016/j.heliyon.2024.e31211
M3 - Article
AN - SCOPUS:85193440920
SN - 2405-8440
VL - 10
JO - Heliyon
JF - Heliyon
IS - 10
M1 - e31211
ER -